Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Neoplasm Female × venetoclax × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 33 Leukemia, Lymphocytic, Chronic, B-Cell 24 Myelodysplastic Syndromes 12 Leukemia, Myelomonocytic, Chronic 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms 6 Recurrence 5 Lymphoma, Mantle-Cell 5 Burkitt Lymphoma 5 Myeloproliferative Disorders 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Lymphoma, B-Cell 4 Leukemia, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Primary Myelofibrosis 2 Leukemia, Biphenotypic, Acute 2 Waldenstrom Macroglobulinemia 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1

Interventions

venetoclax 1 palbociclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡